Genomed Spólka Akcyjna (WSE:GEN)
Poland · Delayed Price · Currency is PLN 37.80
+0.80 (2.16%)
Last updated: Nov 2, 2026, 12:45 PM CET
Genomed Spólka Akcyjna Market Cap
Genomed Spólka Akcyjna has a market cap or net worth of 49.95 million as of November 3, 2026. It is the 39,931st most valuable company in the world and the 346th biggest in Poland. Its market cap has increased by 36.96% in one year.
Market Cap
49.95M
Enterprise Value
42.62M
Revenue
30.64M
Global Rank
Country Rank
#346 Poland
PE Ratio
14.25
ChartMarket Cap Chart
Since May 30, 2011, Genomed Spólka Akcyjna's market cap has increased from 37.00M to 49.95M, an increase of 35.00%. That is a compound annual growth rate of 1.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 49.95M | 56.20% |
| Dec 29, 2025 | 31.98M | -9.02% |
| Dec 30, 2024 | 35.15M | -10.74% |
| Dec 29, 2023 | 39.37M | -12.35% |
| Dec 30, 2022 | 44.92M | -0.58% |
| Dec 30, 2021 | 45.19M | 3.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 4.98B |
| NEUCA | 3.10B |
| Synektik Spólka Akcyjna | 2.75B |
| Voxel | 1.59B |
| Urteste | 64.25M |
| Read-Gene | 55.41M |
| Biogened | 46.67M |
| Genomtec | 43.43M |